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Seven patients with severe aortic stenosis underwent per- 
cutaneous aortic balloon valvuloplasty in preparation for 
major noncardiac surgery. There were four men and three 
women (mean age 82 C 1.3 years, range 78 to 88). A 
significant reduction in the transaortic pressure gradient 
from 77 f 7.8 to 31 f 6.2 mm Hg (p = 0.002) and increase 
in calculated aortic valve area from 0.5 f 0.1 to 1.0 + 0.3 
cm’ (p = 0.05) was noted. Three of the seven procedures 
were performed anterograde with use of transseptal punc- 
ture: two of the three because of abdominal aortic aneu- 
rysm and one because of peripheral vascular disease. 
All seven patients underwent uncomplicated noncardiac 
surgery under general anesthesia 10 -C 4.3 days (range 0 to 
29) after aortic valvuloplasty. One patient had exploratory 
laparotomy, one underwent stabilization of a hip fracture 
and two underwent resection of an abdominal aortic aneu- 
rysm. Of the three other patients who underwent colec- 
tomy, one had repeat aortic valvuloplasty and repair of a 
hip fracture 7 months later and one required exploratory 
laparotomy without repeat valvuloplasty 7 weeks later. 
Percutaneous aortic balloon valvuloplasty is an effective 
and safe procedure that may reduce the risk of general 
anesthesia and major noncardiac surgery in elderly patients 
with aortic stenosis. 
(.I Am Co11 Cardiol1989;13:103941) 
The management of patients with significant aortic stenosis 
and other noncardiac surgical problems poses a challenging 
problem in the perioperative period. These patients are at 
increased risk for cardiac complications, including myocar- 
dial infarction, congestive heart failure resulting from 
changes in intravascular volume status and supraventricular 
tachyarrhythmias (I). 
Percutaneous balloon valvuloplasty offers the cardiologist 
an additional treatment modality in the management of the 
elderly patient with aortic stenosis. Initial series (2-6) have 
shown a significant reduction of transaortic gradient and 
consequent increase in calculated aortic valve area associated 
with an acceptable intraprocedure risk in the great majority of 
patients with aortic stenosis. Although follow-up studies have 
shown these favorable hemodynamic effects to be short-lived 
and the restenosis rate to be as high as 53% (5), the immediate 
and symptomatic improvement produced by aortic balloon 
valvuloplasty can afford a window that simplifies the manage- 
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ment of patients with significant aortic stenosis and an urgent 
need for noncardiac surgery. 
In the present study we report our experience with the 
use of aortic balloon valvuloplasty in the preoperative man- 
agement of patients with severe aortic stenosis and other 
conditions requiring surgical intervention. 
Methods 
Study patients. Between August 1986 and March 1988, 
I65 patients were referred to our cardiac catheterization 
laboratory for aortic valvuloplasty. Of these patients, seven, 
four men and three women, required aortic valvuloplasty 
before noncardiac surgery. These patients were recom- 
mended for aortic valvuloplasty before other surgery be- 
cause they were believed to be at extraordinarily high risk 
for surgery in light of their advanced age and the presence of 
severe calcific aortic stenosis. No patient in the study group 
had a previous history of myocardial infarction, stroke, 
syncope or angina pectoris. None had significant coronary 
artery disease (coronary stenosis >50%), > 1+ aortic regur- 
gitation or other valvular heart disease. 
All patients underwent a noncardiac surgical procedure 
within 6 weeks of aortic valvuloplasty. Two patients under- 
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Table 1. Clinical Data of Seven Patients Undergoing Aortic Balloon Valvuloplasty Before Noncardiac Surgery 
Patient 
No. 
As 
(yrl NYHA Class Diagnosis Procedure 
Days 
After 
PAV 
1 80 IV 
2 82 III 
3 81 II 
4 83 III 
5 88 II 
6 87 III 
7 78 II 
Rectal Ca Right colectomy, liver biopsy, incisional I 
hernia repair* 
Hip fx Stabilization of hip fx 0 
Colon Ca Left colectomyt 29 
Duodenal Ca Exploratory laparotomy 0 
AAA AAA resection 23 
Rectal Ca Right colectomy!: 7 
AAA AAA resection 4 
*Underwent repeat valvoloplasty and repair of hip fracture 7 months later: tdied 7 months later of an unrelated condition; tunderwent exploratory laparotomy 
and lysis of adhesions 7 weeks later. AAA = abdominal aortic aneurysm; Ca = carcinoma; fx = fracture; NYHA = New York Heart Association; PAV = 
percutaneous aortic valvuloplasty. 
went surgery the same day as percutaneous aortic valvulo- 
plasty. 
Balloon valvuloplasty procedure. Four of the seven pa- 
tients underwent retrograde percutaneous aortic valvuloplasty 
by way of the femoral artery as described by Cribier et al. (2). 
The other three patients underwent anterograde percutaneous 
aortic valvuloplasty after transseptal puncture as previously 
described (6). In two of these patients, anterograde valvulo- 
plasty was performed because of the presence of a large 
abdominal aortic aneurysm, and in the third patient because of 
severe peripheral vascular disease. Single balloon valvulo- 
plasty was performed in five patients, four with a 20 mm 
balloon and one with a 25 mm balloon. Two patients underwent 
the procedure with a double balloon technique (one retrograde, 
one anterograde) each with a combination of 20 and 15 mm 
balloons. Transaortic pressure gradient was obtained by simul- 
taneous measurement of left ventricular and ascending aortic 
pressures. All procedures were done with intercurrent moni- 
toring of peripheral arterial pressure from the radial artery and 
pulmonary artery pressure. Oximetry was performed before 
and after the procedure. After valvuloplasty, aortography in 
the 30” right anterior oblique projection was performed to 
assess the degree of aortic regurgitation. 
Measurements. Cardiac output was measured with use of 
both the thermodilution and Fick methods. This is done as a 
matter of protocol in all cases of valvular heart disease in our 
laboratory to rule out skewing of the thermodilution cardiac 
output by tricuspid regurgitation. Oxygen saturation was 
measured at the level of the superior vena cava, main 
pulmonary artery and left ventricle. A satisfactory valvulo- 
plasty result was defined as >50% reduction in peak to peak 
gradient measured simultaneously from the left ventricle and 
the ascending aorta. Aortic valve area was calculated with 
use of the Gorlin equation (7). 
Statistical analysis. Clinical data are expressed as mean 
values t SEM. Comparison of means was made with use of 
paired Student’s t tests. Significance of differences of dis- 
crete variables was evaluated with the Fisher exact test. A 
p value co.05 was considered significant. 
Results 
Clinical and hemodynamic data (Tables 1 and 2). The 
study group consisted of three women and four men (Table 
1). Their mean age was 82 +- 1.3 years (range 78 to 88); all 
seven patients were in normal sinus rhythm. No patient had 
greater than mild (1 +) aortic regurgitation. Four of the seven 
patients had severe symptomatic heart failure. Three were in 
New York Heart Association functional class II, three were 
in class III and one was in class IV. 
After the valvuloplasty procedure, there was a decrease in 
the mean systolic transaortic gradient from 77 t 7.8 to 31 t 6.2 
mm Hg and an increase in the calculated aortic valve area from 
0.5 +- 0.1 to 1.0 ? 0.3 cm2 (Table 2). Because there was no 
significant difference between cardiac output values deter- 
mined by the thermodilution and Fick methods, cardiac out- 
puts used in calculations are those determined by thermodilu- 
tion. No patient had a significant change in cardiac output. No 
significant changes were noted in pulmonary capillary wedge 
pressure or systemic or pulmonary vascular resistance. 
Table 2. Hemodynamic Data in Seven Patients Undergoing Aortic 
Balloon Valvuloplasty 
Patient 
No. 
I 
2 
3 
4 
5 
6 
7 
Mean 
+SEM 
Mean 
Transaortic 
Gradient 
(mm Hg) 
Pre Post 
45 2s 
90 53 
70 33 
95 25 
65 25 
70 5 
IO5 50 
71 31* 
k7.8 26.2 
Cardiac Output 
Wmin) 
Pre Post 
4.3 3.3 
5.1 4.6 
4.1 5.4 
5.4 5.2 
4.3 3.3 
3.3 3.7 
4.0 3.1 
4.4 4.1 
20.3 LO.4 
Aortic Valve 
Area (cm’) 
Pre Post 
0.6 0.8 
0.4 0.6 
0.3 0.5 
0.4 0.6 
0.5 I.1 
0.6 2.6 
0.4 0.5 
0.5 I .ot 
to.1 to.3 
*p = 0.0002; tp = 0.05. Post = after valvuloplasty; Pre = before 
valvuloplasty. 
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Noncardiac surgical procedures. All seven patients in the 
study group underwent an uncomplicated noncardiac surgi- 
cal procedure under general anesthesia 10 5 4.3 days (range 
0 to 29) after aortic valvuloplasty. One patient (Case 2) 
underwent stabilization of an intertrochanteric femoral frac- 
ture on the day of aortic valvuloplasty. A second patient 
(Case 4) underwent laparotomy the day of aortic valvulo- 
plasty. One patient with colonic carcinoma and class IV 
congestive heart failure (Case I) had right colectomy, liver 
biopsy. Stamm gastrostomy and repair of incisional hernia 7 
days after aortic valvuloplasty. After valvuloplasty he was 
clinically in class II. Seven months later he was readmitted 
with pneumonia and combined cardiac and respiratory fail- 
ure; during his treatment he underwent repeat aortic valvu- 
loplasty. He was readmitted a second time 4 weeks later with 
a hip fracture; he then underwent uncomplicated repair of 
the fracture. A third patient with known rectal carcinoma 
(Case 6) underwent uncomplicated right colectomy and 
colostomy 7 days after aortic valvuloplasty; 7 weeks later he 
developed a small bowel obstruction. Preoperative noninva- 
sive evaluation revealed no evidence of aortic restenosis and 
he underwent uncomplicated exploratory laparotomy. lysis 
of intraabdominal adhesions and revision of the colostomy 
site. One patient (Case 3) underwent left colectomy 29 days 
after aortic valvuloplasty and died of an unrelated illness 7 
months later. Each of the two patients with abdominal aortic 
aneurysm (Cases 5 and 7) underwent uncomplicated resec- 
tion after anterograde aortic valvuloplasty. 
Complications. There were no deaths, strokes or conduc- 
tion abnormalities associated with aortic valvuloplasty ob- 
served in this group. None of the three patients undergoing 
transseptal catheterization developed evidence of left to 
right shunting. One patient developed a pseudoaneurysm of 
the femoral artery and required exploration and repair after 
the procedure. None of the patients developed an increase in 
aortic regurgitation with valvuloplasty. 
Discussion 
Cardiac risk and major general surgical procedures. Pa- 
tients undergoing a general surgical procedure are subject to 
multiple stresses. Changes in cardiovascular hemodynamics 
and cardiac rhythm are usually well tolerated and easily 
managed. However, when severe valvular aortic stenosis is 
superimposed on the challenge of general anesthesia and a 
prolonged surgical procedure, patient management is more 
difficult. Although the overall risk of noncardiac surgery in 
these patients is usually related to their underlying functional 
class, patients with severe aortic stenosis have a higher risk 
for complications (1,8). Because of the decrease in functional 
reserve of the myocardium in these patients, they are much 
less tolerant of rapid fluid shifts, hypoxia, myocardial isch- 
emia and tachyarrhythmias during the perioperative period. 
Role of aortic valvuloplasty in decreasing operative risk of 
noncardiac surgery. Our experience with these seven pa- 
tients shows that aortic valvuloplasty may be helpful in the 
perioperative management of patients with calcific aortic 
stenosis who need a major surgical procedure. All seven 
patients had partial relief of their aortic valve gradient with 
valvuloplasty. One patient in the study group (Case 6) had an 
increase in calculated aortic valve area of 2.0 cm2 whereas 
the average change in calculated valve area in the remainder 
of the group was 0.25 2 0.07 cm’. The increase in calculated 
aortic valve area with aortic valvuloplasty is related to the 
underlying valve disease. It has been previously shown (5) 
that the hemodynamic improvement in patients undergoing 
valvuloplasty is greater when the calculated aortic valve area 
before the procedure is >0.6 cm’. Furthermore, it is possible 
that the marked reduction in the transaortic gradient in 
Patient 6 is due to the opening of fused commissures in 
addition to fracture of valvular calcium. The only complica- 
tion in the study group was the development of a pseudo- 
aneurysm of the femoral artery through which the procedure 
was performed. None of our seven patients had any serious 
complications of their subsequent surgical procedure. 
Conclusions. Follow-up studies of patients undergoing 
percutaneous aortic valvuloplasty have shown that the bene- 
ficial hemodynamic effects of the procedure may be short- 
lived. The restenosis rate is high and usually occurs during the 
first I2 months. The long-term effects of valvuloplasty on the 
clinical course of aortic stenosis are not yet known. For these 
reasons we suggest that aortic valvuloplasty, when performed 
just before surgery. may be a valuable technique to create a 
“window of opportunity” to decrease the risk of noncardiac 
surgery in patients with severe valvular aortic stenosis. 
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